COX17
Gene Information
- Official Symbol: COX17
- Official Name: cytochrome c oxidase copper chaperone COX17
- Aliases and Previous Symbols: N/A
- Entrez ID: 10063
- UniProt: Q14061
- Interactions: BioGRID
- PubMed articles: Open PubMed
- OMIM: Open OMIM
Function Summary
- Entrez Summary: N/A
- UniProt Summary: Copper chaperone for cytochrome c oxidase (COX). Binds two copper ions and deliver them to the Cu(A) site of COX (By similarity). {ECO:0000250}.
Pfam Domains GO Terms
Pfam Domains
| COX17 |
GO Terms
| positive regulation of cytochrome-c oxidase activity |
| copper chaperone activity |
| positive regulation of electron transfer activity |
| regulation of cytochrome-c oxidase activity |
| cuprous ion binding |
| regulation of electron transfer activity |
| copper ion transport |
| mitochondrial respiratory chain complex IV assembly |
| regulation of proton transport |
| respiratory chain complex IV assembly |
| cytochrome complex assembly |
| positive regulation of oxidoreductase activity |
| copper ion binding |
| mitochondrial intermembrane space |
| regulation of oxidoreductase activity |
| mitochondrial respiratory chain complex assembly |
| positive regulation of ion transmembrane transporter activity |
| positive regulation of transporter activity |
| transition metal ion transport |
| positive regulation of cation transmembrane transport |
| positive regulation of ion transmembrane transport |
| regulation of generation of precursor metabolites and energy |
| positive regulation of transmembrane transport |
| regulation of ion transmembrane transporter activity |
| regulation of transmembrane transporter activity |
| positive regulation of ion transport |
| regulation of transporter activity |
| regulation of cation transmembrane transport |
| generation of precursor metabolites and energy |
| mitochondrion organization |
| regulation of ion transmembrane transport |
| heart development |
| regulation of transmembrane transport |
| metal ion transport |
| regulation of ion transport |
| brain development |
| head development |
| cation transport |
| cellular protein-containing complex assembly |
| circulatory system development |
| positive regulation of cell population proliferation |
| central nervous system development |
| positive regulation of transport |
| ion transport |
| positive regulation of catalytic activity |
| protein-containing complex assembly |
| regulation of cell population proliferation |
| positive regulation of molecular function |
| protein-containing complex subunit organization |
| regulation of transport |
CRISPR Data
Compound Hit Most Correlated Genes in Chemogenomics Tissues where Essential in the Avana Dataset (DepMap 20Q1)
Compound Hit
Most Correlated Genes in Chemogenomics
| Gene | Correlation |
|---|---|
| HSD17B10 | 0.619 |
| MRPS6 | 0.6 |
| COX16 | 0.599 |
| MRPL23 | 0.591 |
| MRPS21 | 0.59 |
| MRPS16 | 0.58 |
| MRPS5 | 0.573 |
| DARS2 | 0.572 |
| COA5 | 0.558 |
| MRPL47 | 0.553 |
| TARS2 | 0.552 |
| MRPL21 | 0.548 |
| GFM1 | 0.547 |
| SELRC1 | 0.545 |
| SARS2 | 0.544 |
| MTPAP | 0.544 |
| DAP3 | 0.543 |
| YARS2 | 0.541 |
| RPUSD4 | 0.538 |
| COA3 | 0.534 |
| FASTKD5 | 0.534 |
| MRPS14 | 0.532 |
| BCS1L | 0.528 |
| MRPL15 | 0.528 |
| MRPS2 | 0.528 |
| SCO2 | 0.526 |
| KIAA0391 | 0.523 |
| MRPS34 | 0.52 |
| MRPL53 | 0.516 |
| COX6C | 0.514 |
| WBSCR16 | 0.511 |
| MRPS33 | 0.504 |
| MRPS25 | 0.503 |
| COA6 | 0.503 |
| RARS2 | 0.501 |
| PARS2 | 0.5 |
| PNPT1 | 0.499 |
| COX7B | 0.499 |
| NARS2 | 0.497 |
| HARS2 | 0.495 |
| QRSL1 | 0.488 |
| EARS2 | 0.487 |
| SUPV3L1 | 0.487 |
| MARS2 | 0.485 |
| MRPS26 | 0.484 |
| TUFM | 0.483 |
| VARS2 | 0.482 |
| COX15 | 0.479 |
| TOMM22 | 0.475 |
| MRPS12 | 0.471 |
| PDSS1 | 0.47 |
| UQCRC2 | 0.47 |
| COX6B1 | 0.468 |
| MRPL18 | 0.466 |
| MRP63 | 0.463 |
| GFM2 | 0.462 |
| MRPS9 | 0.461 |
| FTSJ2 | 0.459 |
| FARS2 | 0.459 |
| NDUFB11 | 0.459 |
| MRPL4 | 0.455 |
| AIFM1 | 0.454 |
| MRPS18A | 0.453 |
| GATC | 0.453 |
| COX11 | 0.452 |
| LARS2 | 0.452 |
| MTG2 | 0.451 |
| SLC25A26 | 0.446 |
| MRPS24 | 0.445 |
| PET117 | 0.443 |
| RBFA | 0.442 |
| METTL17 | 0.437 |
| MRPL34 | 0.437 |
| MRPL11 | 0.434 |
| NDUFAF7 | 0.433 |
| TRIAP1 | 0.432 |
| LSM10 | 0.432 |
| RNASEH1 | 0.431 |
| MRPL42 | 0.431 |
| UQCRQ | 0.429 |
| MRPL3 | 0.429 |
| MRPS11 | 0.428 |
| MRPL45 | 0.427 |
| ATP5D | 0.426 |
| C12orf65 | 0.425 |
| NDUFAF3 | 0.424 |
| MRPL55 | 0.424 |
| MRPL52 | 0.423 |
| C10orf2 | 0.422 |
| PET100 | 0.421 |
| CYCS | 0.42 |
| NDUFA3 | 0.419 |
| ATXN10 | 0.418 |
| COX5A | 0.417 |
| TEFM | 0.417 |
| TOMM20 | 0.415 |
| ATP5SL | 0.415 |
| MRPL36 | 0.414 |
| PPA2 | 0.414 |
| ELAC2 | 0.412 |
| C17orf89 | 0.412 |
| GTPBP10 | 0.412 |
| CHCHD4 | 0.41 |
| DHX30 | 0.408 |
| TRMT10C | 0.408 |
| CHCHD1 | 0.407 |
| MRPL51 | 0.407 |
| MRPL27 | 0.406 |
| MRPL13 | 0.404 |
| COX7C | 0.404 |
| AASDHPPT | 0.402 |
| RPUSD3 | 0.401 |
| SRD5A3 | 0.401 |
Tissues where Essential in the Avana Dataset (DepMap 20Q1)
Global Fraction of Cell Lines Where Essential: 175/739
| Tissue | Fraction Of Cell Lines Where Essential |
|---|---|
| 1290807.0 | 0/1 |
| 909776.0 | 0/1 |
| bile duct | 8/28 |
| blood | 9/28 |
| bone | 9/26 |
| breast | 9/33 |
| central nervous system | 8/56 |
| cervix | 1/4 |
| colorectal | 4/17 |
| esophagus | 3/13 |
| fibroblast | 0/1 |
| gastric | 4/16 |
| kidney | 3/21 |
| liver | 7/20 |
| lung | 23/75 |
| lymphocyte | 7/16 |
| ovary | 3/26 |
| pancreas | 1/24 |
| peripheral nervous system | 6/16 |
| plasma cell | 3/15 |
| prostate | 0/1 |
| skin | 7/24 |
| soft tissue | 1/9 |
| thyroid | 0/2 |
| upper aerodigestive | 3/22 |
| urinary tract | 4/29 |
| uterus | 0/5 |
Essentiality in NALM6
- Essentiality Rank: 189
- Expression level (log2 read counts): 3.5
Expression Distribution
COX17 Expression in NALM6 Cells: 3.5